Anti-Inflammatory Potential of 3-Hydroxy-β-Ionone from Moringa oleifera: Decreased Transendothelial Migration of Monocytes Through an Inflamed Human Endothelial Cell Monolayer by Inhibiting the IκB-α/NF-κB Signaling Pathway
Thitiya Luetragoon, Krai Daowtak, Yordhathai Thongsri, Pachuen Potup, Philip C Calder, Kanchana Usuwanthim, Guglielmina Froldi · 2024
Read Anti-Inflammatory Potential of 3-Hydroxy-β-Ionone from Moringa oleifera: Decreased Transendothelial Migration of Monocytes Through an Inflamed Human Endothelial Cell Monolayer by Inhibiting the IκB-α/NF-κB Signaling Pathway by Thitiya Luetragoon, Krai Daowtak, Yordhathai Thongsri, Pachuen Potup, Philip C Calder, Kanchana Usuwanthim, Guglielmina Froldi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678794.txt.
Description
Thitiya Luetragoon and co-authors present a 2024 study of a moringa leaf compound that calms inflamed blood vessel walls. Vessel inflammation invites white cells to cross into tissue, a step in many chronic diseases. In a lab model of vessel lining cells, the team dosed cells with leaf extract, a fraction of it, and its active part, 3-hydroxy-β-ionone, before sparking inflammation.
All three doses cut the output of flame signals and sticky docking proteins on the cell surface. A master flame switch inside the cells also quieted. Fewer blood cells stuck to the lining, and fewer crossed it. The compound thus brakes the cross-over step itself. Leaf-based agents of this kind could one day support vessel care, pending live tests.
Catalog record
| CREATOR | Thitiya Luetragoon, Krai Daowtak, Yordhathai Thongsri, Pachuen Potup, Philip C Calder, Kanchana Usuwanthim, Guglielmina Froldi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |